Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease

Clinical Nephrology

Volumn 76, Issue 2, 2011, Pages 99-103

  Battistella, M ^a   Richardson, R M A ^a   Bargman, J M ^a   Chan, C T ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Anemia; Bone marrow; Cinacalcet; Erythropoietin; Parathyroid hormone

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CALCIUM PHOSPHATE; CINACALCET; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARATHYROID HORMONE; PHOSPHOROUS ACID;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HEMODIALYSIS; HORMONAL REGULATION; HUMAN; KIDNEY FAILURE; MALE; PARATHYROIDECTOMY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; UREMIA;

ANEMIA; COHORT STUDIES; DRUG INTERACTIONS; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052359741     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106640     Document Type: Article

References (19)

1. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999; 10: 610-619.
2. Xia H, Ebben J, Ma JZ, Collins AJ. Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol. 1999; 10: 1309-1316.
3. Nissenson AR, Nimer SD, Wolcott DL. Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects. Ann Intern Med. 1991; 114: 402-416.
4. Ly J, Marticorena R, Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis. 2004; 44: 715-719.
5. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med. 1993; 328: 171-175.
6. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350: 1516-1525.
7. Washio M, Iseki K, Onoyama K, Oh Y, Nakamoto M, Fujimi S, Fujishima M. Elevation of serum erythropoietin after subtotal parathyroidectomy in chronic haemodialysis patients. Nephrol Dial Transplant. 1992; 7: 121-124.
8. Ureña P, Eckardt KU, Sarfati E, Zingraff J, Zins B, Roullet JB, Roland E, Drüeke T, Kurtz A. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron. 1991; 59: 384-393.
9. Zingraff J, Drüeke T, Marie P, Man NK, Jungers P, Bordier P. Anemia and secondary hyperparathyroidism. Arch Intern Med. 1978; 138: 1650-1652.
10. Albitar S, Genin R, Fen-Chong M, Serveaux MO, Schohn D, Chuet C. High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrol Dial Transplant. 1997; 12: 514-518.
11. Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-García R, Valderrábano F. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron. 1998; 78: 23-27.
12. Calvi LM. Osteoblastic activation in the hematopoietic stem cell niche. Ann N Y Acad Sci. 2006; 1068: 477-488.
13. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425: 841-846.
14. Rabbany SY, Heissig B, Hattori K, Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med. 2003; 9: 109-117.
15. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997; 185: 111-120.
16. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999; 283: 845-848.
17. Chan CT, Liu PP, Arab S, Jamal N, Messner HA. Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells. J Am Soc Nephrol. 2009; 20: 665-671.
18. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006; 439: 599-603.
19. Drüeke TB. Haematopoietic stem cells - role of calcium-sensing receptor in bone marrow homing. Nephrol Dial Transplant. 2006; 21: 2072-2074.